IL90594A - Cdnas coding for members of the carcinoembryonic antigen family - Google Patents

Cdnas coding for members of the carcinoembryonic antigen family

Info

Publication number
IL90594A
IL90594A IL90594A IL9059489A IL90594A IL 90594 A IL90594 A IL 90594A IL 90594 A IL90594 A IL 90594A IL 9059489 A IL9059489 A IL 9059489A IL 90594 A IL90594 A IL 90594A
Authority
IL
Israel
Prior art keywords
members
carcinoembryonic antigen
antigen family
cdnas coding
cdnas
Prior art date
Application number
IL90594A
Other languages
English (en)
Other versions
IL90594A0 (en
Original Assignee
Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Diagnostics Inc filed Critical Molecular Diagnostics Inc
Publication of IL90594A0 publication Critical patent/IL90594A0/xx
Publication of IL90594A publication Critical patent/IL90594A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL90594A 1988-06-16 1989-06-13 Cdnas coding for members of the carcinoembryonic antigen family IL90594A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20767888A 1988-06-16 1988-06-16
US07/274,107 US5122599A (en) 1986-08-13 1988-11-21 CDNAS coding for members of the carcinoembryonic antigen family

Publications (2)

Publication Number Publication Date
IL90594A0 IL90594A0 (en) 1990-01-18
IL90594A true IL90594A (en) 1997-11-20

Family

ID=26902468

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90594A IL90594A (en) 1988-06-16 1989-06-13 Cdnas coding for members of the carcinoembryonic antigen family

Country Status (13)

Country Link
US (1) US5122599A (de)
EP (1) EP0346710B1 (de)
JP (1) JPH02107190A (de)
AU (1) AU628348B2 (de)
CA (1) CA1340787C (de)
DE (1) DE68910590T2 (de)
DK (1) DK175605B1 (de)
ES (1) ES2059621T3 (de)
FI (1) FI892910L (de)
IE (1) IE62161B1 (de)
IL (1) IL90594A (de)
NO (1) NO892220L (de)
NZ (1) NZ229514A (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346999A (en) * 1985-01-18 1994-09-13 Applied Biosystems, Inc. Method of nucleic acid extraction
US5274087A (en) * 1986-08-13 1993-12-28 Molecular Diagnostics, Inc. cDNA coding for carcinoembryonic antigen (CEA)
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
US6765087B1 (en) * 1992-08-21 2004-07-20 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
CA2116640A1 (en) * 1993-03-25 1994-09-26 Alexey Terskikh Carcinoembryonic antigen derivatives
WO1998012354A1 (en) * 1996-09-19 1998-03-26 Affymetrix, Inc. Identification of molecular sequence signatures and methods involving the same
US6391550B1 (en) * 1996-09-19 2002-05-21 Affymetrix, Inc. Identification of molecular sequence signatures and methods involving the same
US20070048860A1 (en) * 1997-10-10 2007-03-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Carcinoembryonic antigen (CEA) peptides
WO2000052161A2 (en) * 1999-03-01 2000-09-08 Incyte Pharmaceuticals, Inc. Leukocyte- and blood-associated proteins
CA2388337C (en) 1999-10-22 2013-01-08 Aventis Pasteur Limited Method of inducing and/or enhancing an immune response to tumor antigens
US6949629B2 (en) * 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins
ES2290449T3 (es) 2002-04-09 2008-02-16 Sanofi Pasteur Limited Acido nucleico de cea modificado y vectores de expresion.
WO2004092216A1 (en) * 2003-04-15 2004-10-28 Trangene S.A. Carcinoembryonic antigen (cea) lacking a signal peptide, nucleic acid encoding it and fusion of cea with a t cell epitope and their use for the treatment and/or prophylaxis of cancer
CA2550583C (en) * 2003-10-08 2013-01-15 Sanofi Pasteur, Inc. Modified cea /b7 vector
CA2555013C (en) 2004-02-11 2013-10-15 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Carcinoembryonic antigen fusions and uses thereof
JP4852887B2 (ja) * 2004-05-28 2012-01-11 凸版印刷株式会社 掲示板
US8632970B2 (en) 2005-05-09 2014-01-21 Affymetrix, Inc. Multiplex capture of nucleic acids
EP1880206B1 (de) * 2005-05-09 2012-11-14 Affymetrix, Inc. Multiplex-einfang von nukleinsäuren
US7803541B2 (en) * 2005-05-12 2010-09-28 Panomics, Inc. Multiplex branched-chain DNA assays
DK2500439T4 (da) * 2005-06-20 2017-11-13 Advanced Cell Diagnostics Inc Kits og produkter til detektering af nukleinsyrer i individuelle celler og til identifikation af sjældne celler fra store heterogene cellepopulationer
WO2007044427A2 (en) * 2005-10-05 2007-04-19 Panomics, Inc. Detection of nucleic acids from whole blood
JP5779352B2 (ja) 2008-03-14 2015-09-16 サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー 複製欠損フラビウイルスワクチンおよびワクチンベクター
BRPI0906261A2 (pt) * 2008-03-31 2015-07-07 Genentech Inc "métodos de diagnóstico de um subtipo de asma em uma amostra de paciente, usos de um agente terapêutico e kits de diagnóstico de um subtipo de asma em uma amostra de paciente"
US8658361B2 (en) 2010-10-21 2014-02-25 Advanced Cell Diagnostics, Inc. Ultra sensitive method for in situ detection of nucleic acids
RU2578468C2 (ru) 2010-12-16 2016-03-27 Дженентек, Инк. Способы диагностики и лечения, связанные с ингибированием th2
WO2014140938A2 (en) 2013-03-14 2014-09-18 Centre Hospitalier Universitaire Vaudois Immunological methods
US9753036B2 (en) 2014-04-29 2017-09-05 Edp Biotech Corporation Methods and compositions for screening and detecting biomarkers
EP3362462B1 (de) 2015-10-12 2021-07-21 Advanced Cell Diagnostics, Inc. In-situ-detektion von nukleotidvarianten bei proben mit hohem rauschen sowie zugehörige zusammensetzungen und verfahren
CN110198733B (zh) 2016-09-28 2024-04-30 巴法里安诺迪克有限公司 用于增强痘病毒中转基因的稳定性的组合物和方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228236A (en) * 1978-05-15 1980-10-14 Northwestern University Process of producing carcinoembryonic antigen
US4489167A (en) * 1981-06-02 1984-12-18 Baxter Travenol Laboratories, Inc. Methods and compositions for cancer detection
IL75994A0 (en) * 1985-08-01 1985-12-31 Israel Inst Biolog Res Process for the production of a substance for monitoring cancer patients
EP0263933B1 (de) * 1986-08-13 1993-10-20 Miles Inc. Karzinoembryonisches Antigen kodierende cDNS

Also Published As

Publication number Publication date
NZ229514A (en) 1991-05-28
AU628348B2 (en) 1992-09-17
AU3644389A (en) 1989-12-21
IE891945L (en) 1989-12-16
NO892220L (no) 1989-12-18
EP0346710A2 (de) 1989-12-20
ES2059621T3 (es) 1994-11-16
FI892910A0 (fi) 1989-06-14
DK175605B1 (da) 2004-12-20
DE68910590T2 (de) 1994-03-17
FI892910A7 (fi) 1989-12-17
IE62161B1 (en) 1994-12-28
DK296189A (da) 1989-12-17
IL90594A0 (en) 1990-01-18
CA1340787C (en) 1999-10-12
EP0346710B1 (de) 1993-11-10
FI892910L (fi) 1989-12-17
EP0346710A3 (de) 1991-09-11
DE68910590D1 (de) 1993-12-16
NO892220D0 (no) 1989-06-01
JPH02107190A (ja) 1990-04-19
DK296189D0 (da) 1989-06-15
US5122599A (en) 1992-06-16

Similar Documents

Publication Publication Date Title
IL90594A (en) Cdnas coding for members of the carcinoembryonic antigen family
AU3107289A (en) Chimeric antibodies directed against human carcinoembryonic antigen
EP0419245A3 (en) Coding seismic sources
EP0431939A3 (en) Post-collation copying
AU554304B2 (en) Determination of carcinoembryonic antigen
GB8515548D0 (en) Reflective particles
EP0314158A3 (en) Resin particles
AU1944088A (en) Nuclear antigen la
IL85955A0 (en) Human tumor-associated antigen
GB2118999B (en) Reflective kerbs or the like
GB2224693B (en) Digital copier
GB2251402B (en) Procedure for the manufacture of contour-stable objects
GB2238444B (en) Digital coder
ZA894553B (en) Cdnas conding for members of the carcinoembryonic antigen family
IL95999A0 (en) Tumor-associated antigen
EP0423333A4 (en) Anti-endoserine antibody
GB8703354D0 (en) Coder
GB8812137D0 (en) Antibodies
GB2212841B (en) Reflectors
GB8730170D0 (en) Reflectors
GB8803757D0 (en) Antigens against autoimmune diseases
IL106425A0 (en) Chimeric antibodies directed against human carcinoembryonic antigen
GB8812353D0 (en) Antibodies
ZA891069B (en) Antibodies
BG45849A1 (en) Mymtem for digital codifying of video- signals

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed